data.valid: Model validation
In lshtm-vimc/prime: PRIME -- Papillomavirus Rapid Interface for Modelling and Economics
data.valid R Documentation
Model validation
Description
A dataset containing data for validation.
Usage
data.valid
Format
A data table with 26 observations of 49 variables.
- Country
Country name
- iso2
ISO2 country code
- WHO Region
WHO region
- World Bank Income Group (2011)
World Bank income group classification (2011)
- Author
Author
- Year
Year of publication
- Title
Title of publication
- Currency
Currency
- Currency year
Currency year
- Conversion to I$2011
International dollar (I$2011)
- ICER vs no prevention
Incremental cost-effectiveness ratio of vaccination versus no prevention (CHECK)
- ICER vs screen
Incremental cost-effectiveness ratio of vaccination versus no prevention (CHECK)
- Denominator
Denominator for health impact
- Vaccine total costs
Vaccine total costs
- Vaccine coverage
Vaccine coverage
- Vaccine efficacy vs vaccine type infection
Vaccine efficacy versus vaccine type infection
- Duration of protection
Duration of protective immunity from vaccination
- Cohort size
Cohort size
- Age at vaccination
Age at vaccination, years
- Cancer treatment cost per episode
Cancer treatment cost per episode, dollars
- Discount rate: costs
Discount rate for costs
- Discount rate: benefits
Discount rate for benefits
- Perspective
Perspective of economic evaluation
- Comparator is no screening
Comparator refers to no scereening, logical (Y/N)
- Time horizon
Time horizon of analysis
- GDP per capita
GDP per capita
- Cervical cancer due to 16/18
Proportion of cervical cancer due to HPV types 16 and 18
- CeCx cost low original
Cervical cancer cost / low / original
- CeCx cost high original
Cervical cancer cost / high / original
- CeCx cost low
Cervical cancer cost / low
- CeCx cost high
Cervical cancer cost / high
- CeCx data available
Cervical cancer data available, logical (Y/N)
- 0-4
0-4 years
- 5-9
5-9 years
- 9-14
9-14 years
- 15-19
15-19 years
- 20-24
20-24 years
- 25-29
25-29 years
- 30-34
30-34 years
- 35-39
35-39 years
- 40-44
40-44 years
- 45-49
45-49 years
- 50-54
50-54 years
- 55-59
55-59 years
- 60-64
60-64 years
- 65-69
65-69 years
- 70-74
70-74 years
- 75-79
75-79 years
- 80+
80+ years
lshtm-vimc/prime documentation built on April 21, 2024, 3:21 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| data.valid | R Documentation |
Model validation
Description
A dataset containing data for validation.
Usage
data.valid
Format
A data table with 26 observations of 49 variables.
- Country
Country name
- iso2
ISO2 country code
- WHO Region
WHO region
- World Bank Income Group (2011)
World Bank income group classification (2011)
- Author
Author
- Year
Year of publication
- Title
Title of publication
- Currency
Currency
- Currency year
Currency year
- Conversion to I$2011
International dollar (I$2011)
- ICER vs no prevention
Incremental cost-effectiveness ratio of vaccination versus no prevention (CHECK)
- ICER vs screen
Incremental cost-effectiveness ratio of vaccination versus no prevention (CHECK)
- Denominator
Denominator for health impact
- Vaccine total costs
Vaccine total costs
- Vaccine coverage
Vaccine coverage
- Vaccine efficacy vs vaccine type infection
Vaccine efficacy versus vaccine type infection
- Duration of protection
Duration of protective immunity from vaccination
- Cohort size
Cohort size
- Age at vaccination
Age at vaccination, years
- Cancer treatment cost per episode
Cancer treatment cost per episode, dollars
- Discount rate: costs
Discount rate for costs
- Discount rate: benefits
Discount rate for benefits
- Perspective
Perspective of economic evaluation
- Comparator is no screening
Comparator refers to no scereening, logical (Y/N)
- Time horizon
Time horizon of analysis
- GDP per capita
GDP per capita
- Cervical cancer due to 16/18
Proportion of cervical cancer due to HPV types 16 and 18
- CeCx cost low original
Cervical cancer cost / low / original
- CeCx cost high original
Cervical cancer cost / high / original
- CeCx cost low
Cervical cancer cost / low
- CeCx cost high
Cervical cancer cost / high
- CeCx data available
Cervical cancer data available, logical (Y/N)
- 0-4
0-4 years
- 5-9
5-9 years
- 9-14
9-14 years
- 15-19
15-19 years
- 20-24
20-24 years
- 25-29
25-29 years
- 30-34
30-34 years
- 35-39
35-39 years
- 40-44
40-44 years
- 45-49
45-49 years
- 50-54
50-54 years
- 55-59
55-59 years
- 60-64
60-64 years
- 65-69
65-69 years
- 70-74
70-74 years
- 75-79
75-79 years
- 80+
80+ years
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.